本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Revolution Medicines, Inc.

190.95
-5.9900-3.04%
盤後191.010.0600+0.03%16:28 EDT
成交量:581.98萬
成交額:11.11億
市值:409.28億
市盈率:-21.40
高:197.10
開:197.00
低:188.18
收:196.94
52周最高:224.31
52周最低:42.18
股本:2.14億
流通股本:1.85億
量比:3.31
換手率:3.15%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
淨資產收益率:-79.09%
總資產收益率:-30.12%
市淨率:15.70
市盈率(LYR):-32.09

資料載入中...

2023/02/27

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/23

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/10

重要事件披露

8-K - Current report
2022/12/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/07

重要事件披露

8-K - Current report
2022/11/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/07

重要事件披露

8-K - Current report
2022/09/30

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/01

重要事件披露

8-K - Current report
2022/08/09

重要事件披露

8-K - Current report
2022/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/22

重要事件披露

8-K - Current report
2022/07/13

重要事件披露

8-K - Current report
2022/06/27

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals